期刊: ONCOLOGY REPORTS, 2023; 49 (3)
HOXA cluster antisense RNA 3 (HOXA-AS3) is considered to be involved in several malignancies, however, its biological function in the progression of e......
期刊: ONCOLOGY REPORTS, 2023; 49 (6)
Colorectal adenoma (CRA) is a premalignant lesion of colorectal cancer. The current treatment is surgical resection, but CRA is prone to recurrence, a......
期刊: ONCOLOGY REPORTS, 2023; 50 (1)
Increasing evidence showed that the substance P (SP)/neurokinin-1 receptor (NK1R) complex is involved in the development of several cancers. However, ......
期刊: ONCOLOGY REPORTS, 2023; 50 (2)
Circular RNAs (circRNAs) are a special class of non-coding RNAs that are widely expressed in tissues and cells. Owing to their lack of a 5 & PRIME......
期刊: ONCOLOGY REPORTS, 2023; 49 (2)
Since the completion of the KHBO1401 study, which evaluated the efficacy of the combination of gemcitabine (GEM) and cisplatin (GC) compared with GC p......
期刊: ONCOLOGY REPORTS, 2023; 49 (3)
Digestive system cancers are the leading cause of cancer-related death worldwide due to their high morbidity and mortality rates. The current treatmen......
期刊: ONCOLOGY REPORTS, 2023; 49 (5)
According to the diverse cellular morphology, lung adenocarcinoma (LUAD) was classified into five pathological subtypes, referred to as follows: High-......
期刊: ONCOLOGY REPORTS, 2023; 49 (5)
Colorectal cancer (CRC) is an aggressive tumor, whose development is considered to be modulated by certain long non-coding RNAs (lncRNAs). Therefore, ......
期刊: ONCOLOGY REPORTS, 2023; 50 (5)
Given the recent advances that have been made with photodynamic therapy (PDT) combined with sonodynamic therapy (SDT) (PDT/SDT; also known as SPDT), t......
期刊: ONCOLOGY REPORTS, 2023; 50 (5)
The involvement of enolase-1 (ENO1), intracellularly or extracellularly, has been implicated in cancer development. Moreover, anticancer activities of......
期刊: ONCOLOGY REPORTS, 2023; 50 (3)
Oxaliplatin (Oxa) is one of the most effective chemotherapeutic drugs used in the treatment of colorectal cancer (CRC). However, the use of this drug ......
期刊: ONCOLOGY REPORTS, 2023; 50 (3)
Systemic therapy has been viewed as the mainstay for de novo metastatic breast cancer (dnMBC). However, as dnMBC is highly heterogeneous both biologic......
期刊: ONCOLOGY REPORTS, 2023; 50 (5)
Extracellular vesicles (EVs) produced by various cells, including tumor cells, carry biomolecules to neighboring cells. In hepatocellular carcinoma (H......